Technology is disrupting the Veristat clinical trial design in the industry. For years, we’ve been used to traditional trials where patients must be present at the leading site or make regular visits. Today, digitization is changing clinical research as we know it. For example, decentralization or hybrid research exists thanks to technology. CROs that haven’t considered the impact of digitization should do so to take their clinical trial planning to the next level.
Virtual Clinical Trials Are Increasingly Becoming Mainstream
Integrating digital health technology into clinical trial planning is a growing trend that has transformed the trial environment by enabling virtual clinical research. By effectively gathering study information at each step and allowing research participants to participate from their homes, virtual trials can increase recruitment and retention. Virtual clinical trials are not only adaptable to patient needs and trial design but also flexible. Processes that are typically performed on-site, such as lab testing, dosage, and patient follow-ups, can be done remotely from home. A hybrid model that combines in-person and on-site visits may occasionally be used by trial directors.
Multiple Data Sources for Researchers and Reducing Participation Barriers to Patients
The pandemic brought up conditions that complicated routine patient visits. This impacted the clinical trial sector. Decentralized clinical trials and digital health are pretty famous today (post-pandemic), which is revolutionizing how sponsors and clinical trial leaders get patient data. For years, the clinical trial sector has used lab and case report forms (CRFs) to gather data. Wearables, the Internet of Things (IoT), imaging, and electronic patient-reported outcomes (ePRO), to name a few, are just a few of the many sources of research data in today’s world. Patients may participate in data collection from the convenience of their homes, reducing the need for in-person clinical trial visits and boosting patient involvement. This lowers site expenses for sponsors and, if done well, might shorten the study’s duration.
Increased Use of Modern Analytics and Reporting Tools
As study methods get more intricate, there is a greater need for tools that can consolidate and analyze data quickly. These technologies offer a dashboard view and a dynamic visual analysis of the clinical, operational, and meta-data during the trial. TrialKit BI from Crucial Data Solution, which compiles clinical trial data onto a single platform, illustrates such technology. Considering security, valuable features, and dependability, pick the product that best meets your requirements.
Improved Holistic Approach to Clinical Data in Operational Management
Clinical trials have long struggled with the integration of operational and clinical data. Organizational and departmental silos and various data collection and storage techniques are to blame for this. For instance, one department could have authority over and exclusive access to genetic data, while another would be primarily interested in operational data. In the clinical study site, this leads to data silos.
All in all, your entire research team may use the data by combining and integrating various obtained data in a trial, making departmental collaboration easier. Many businesses see the shift away from conventional, segregated systems as a risk because of regulatory, financial, and technological challenges. However, these obstacles are simple to overcome when more affordable and adaptable technology develops due to regulatory bodies adapting to market trends.